Paper30179110
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.
Partridge SC and 19 others. Radiology, 2018. Cited by 225 papers, by iCite.
Cite this record
ConductScience Library. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Papers, record 30179110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30179110
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Diffusion Magnetic Resonance Imaging | Major topic |
| Neoadjuvant Therapy | Major topic |
| Breast | |
| Chemotherapy, Adjuvant | |
| Female | |
| Humans | |
| Middle Aged | |
| Prospective Studies | |
| Reproducibility of Results | |
| Treatment Outcome |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P41 EB015894 | NIBIB NIH HHS | United States | P41EB015894 | PubMed and NIH | NIH RePORTER |
| U01 CA080098 | NCI NIH HHS | United States | U01CA080098 | PubMed and NIH | NIH RePORTER |
| U10 CA180801 | NCI NIH HHS | United States | U10CA180801 | PubMed and NIH | NIH RePORTER |
| U01 CA166104 | NCI NIH HHS | United States | U01CA166104 | PubMed and NIH | NIH RePORTER |
| R01 CA132870 | NCI NIH HHS | United States | R01CA132870 | PubMed and NIH | NIH RePORTER |
| U01 CA079778 | NCI NIH HHS | United States | U01CA079778 | PubMed and NIH | NIH RePORTER |
| U01 CA151235 | NCI NIH HHS | United States | U01CA151235 | PubMed and NIH | NIH RePORTER |
| U10 CA080098 | NCI NIH HHS | United States | U01CA080098 | PubMed and NIH | NIH RePORTER |
| U10 CA180794 | NCI NIH HHS | United States | U10CA180794 | PubMed | NIH RePORTER |
| U10 CA180820 | NCI NIH HHS | United States | U10CA180820 | PubMed and NIH | NIH RePORTER |
| R01 CA151326 | NCI NIH HHS | United States | R01CA151326 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01564368 | DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy | Results |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 30179102 | Diffusion-weighted MRI in Multicenter Trials of Breast Cancer: A Useful Measure of Tumor Response? | https://conductscience.org/library/papers/30179102 | PubMed |
| Comment in | 30938630 | Diffusion-weighted MRI in Multicenter Trials of Breast Cancer. | https://conductscience.org/library/papers/30938630 | PubMed |
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19760422 | The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. | Eur Radiol | 2010 | https://conductscience.org/library/papers/19760422 | PubMed |
| 2 | 17785706 | Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17785706 | PubMed |
| 3 | 21220595 | Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21220595 | PubMed |
| 4 | 23928243 | Breast magnetic resonance imaging for monitoring response to therapy. | Magn Reson Imaging Clin N Am | 2013 | https://conductscience.org/library/papers/23928243 | PubMed |
| 5 | 23652844 | Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. | Eur Radiol | 2013 | https://conductscience.org/library/papers/23652844 | PubMed |
| 6 | 25891905 | Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer. | Clin Breast Cancer | 2015 | https://conductscience.org/library/papers/25891905 | PubMed |
| 7 | 27406346 | Adaptive Randomization of Neratinib in Early Breast Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27406346 | PubMed |
| 8 | 22623692 | Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. | Radiology | 2012 | https://conductscience.org/library/papers/22623692 | PubMed |
| 9 | 26624971 | Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. | Radiology | 2016 | https://conductscience.org/library/papers/26624971 | PubMed |
| 10 | 27192501 | Diffusion-Weighted Breast Magnetic Resonance Imaging: A Semiautomated Voxel Selection Technique Improves Interreader Reproducibility of Apparent Diffusion Coefficient Measurements. | J Comput Assist Tomogr | 2016 | https://conductscience.org/library/papers/27192501 | PubMed |
| 11 | 26284600 | Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis. | Magn Reson Imaging | 2015 | https://conductscience.org/library/papers/26284600 | PubMed |
| 12 | 16465174 | Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. | Br J Cancer | 2006 | https://conductscience.org/library/papers/16465174 | PubMed |
| 13 | 21127880 | Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. | Eur Radiol | 2011 | https://conductscience.org/library/papers/21127880 | PubMed |
| 14 | 27690173 | Diffusion-weighted breast MRI: Clinical applications and emerging techniques. | J Magn Reson Imaging | 2017 | https://conductscience.org/library/papers/27690173 | PubMed |
| 15 | 20851939 | Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. | Radiology | 2010 | https://conductscience.org/library/papers/20851939 | PubMed |
| 16 | 3763909 | MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. | Radiology | 1986 | https://conductscience.org/library/papers/3763909 | PubMed |
| 17 | 25816249 | Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy. | PLoS One | 2015 | https://conductscience.org/library/papers/25816249 | PubMed |
| 18 | 11121466 | Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/11121466 | PubMed |
| 19 | 26825883 | Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/26825883 | PubMed |
| 20 | 27798751 | Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations. | Eur Radiol | 2017 | https://conductscience.org/library/papers/27798751 | PubMed |
Cited by171
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 225 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938804 | MRI-Based Prediction of Immunotherapy Response in Breast Cancer: A Systematic Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938804 | PubMed |
| 42782881 | Pretreatment Ki67-to-ADC Ratio Predicts Prognosis in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: A Retrospective Cohort Study. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42782881 | PubMed |
| 42725883 | Diffusion-weighted Imaging and ADC Mapping for Early Prediction of Pathologic Complete Response in Breast Cancer. | Radiol Imaging Cancer | 2026 | https://conductscience.org/library/papers/42725883 | PubMed |
| 42661023 | On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42661023 | PubMed |
| 42587611 | A Practical Machine Learning Model for Predicting Neoadjuvant Response in HER2-Positive Breast Cancer. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42587611 | PubMed |
| 42496228 | Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment. | Radiol Imaging Cancer | 2026 | https://conductscience.org/library/papers/42496228 | PubMed |
| 42452488 | Diagnostic Accuracy of Post-Treatment ADC and MRI Response Assessment for Predicting Pathological Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. | J Clin Med | 2026 | https://conductscience.org/library/papers/42452488 | PubMed |
| 42421685 | A nomogram integrating DCE-MRI imaging features and clinicopathological parameters for predicting pathological complete response in HER2-positive breast cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42421685 | PubMed |
| 42347142 | Image Quality Assessment of Diffusion-Weighted Imaging (DWI) and Its Impact on Apparent Diffusion Coefficient (ADC) as a Quantitative Imaging Biomarker for Predicting Response to Neoadjuvant Chemotherapy in High-Risk Early Breast Cancer. | Tomography | 2026 | https://conductscience.org/library/papers/42347142 | PubMed |
| 42342710 | Multimodal imaging and artificial intelligence for response assessment to neoadjuvant therapy in breast cancer: a comprehensive review. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/42342710 | PubMed |
| 42316062 | Distinguishing Ki67 stratification expression in ER-positive/HER2-negative breast cancers: comparison of advanced MRI diffusion models. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42316062 | PubMed |
| 42201919 | Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer. | PLoS One | 2026 | https://conductscience.org/library/papers/42201919 | PubMed |
| 42168377 | Apparent diffusion coefficient and intravoxel incoherent motion-derived true diffusion serve as early non-contrast longitudinal biomarkers of neoadjuvant chemotherapy response. | Sci Rep | 2026 | https://conductscience.org/library/papers/42168377 | PubMed |
| 42094985 | Associations Between Apparent Diffusion Coefficient Values and Histopathologic Prognostic Factors in Breast Cancer: A Retrospective Study. | Int J Breast Cancer | 2026 | https://conductscience.org/library/papers/42094985 | PubMed |
| 42089524 | The Future of Quantitative Breast Imaging: Integrated to Integral Imaging Biomarkers for Precision Cancer Care, From the AJR Special Series on Quantitative Imaging. | AJR Am J Roentgenol | 2026 | https://conductscience.org/library/papers/42089524 | PubMed |
| 42022355 | MRI-based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. | Precis Radiat Oncol | 2026 | https://conductscience.org/library/papers/42022355 | PubMed |
| 41972087 | Optimizing abbreviated breast MRI protocols for the early assessment of neoadjuvant chemotherapy response in breast cancer. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/41972087 | PubMed |
| 41968995 | The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer. | Cancer Biol Med | 2026 | https://conductscience.org/library/papers/41968995 | PubMed |
| 41897671 | Pre-Treatment Breast MRI Features and ADC Values as Predictors of Pathologic Complete Response in Breast Cancer: A Molecular Subtype-Based Analysis. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41897671 | PubMed |
| 41850007 | Modification of RECIST 1.1 criteria for assessing response in breast tumours treated with radiation therapy using multiparametric breast MRI: Radiology and oncology perspective. | Breast | 2026 | https://conductscience.org/library/papers/41850007 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30179110
GET https://conductscience.org/api/papers/v1/30179110/references?page=2